Search

everythinglearnresearchcommunity

for

Search:↓

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Some chemotherapy can cause permanent hair loss.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

Most patients experienced significant but reversible hair loss during treatment.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

New nanocomposites with copper show promise for healing burn wounds and regenerating skin.

Ginkgo biloba polysaccharides may reduce inflammation and promote hair growth in mice with hair loss.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.